Charles Weston
Stock Analyst at RBC Capital
(0.24)
# 4,574
Out of 5,055 analysts
337
Total ratings
37.8%
Success rate
-5.2%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Reiterated: Buy | €10.00 | €2.62 | +281.97% | 55 | Oct 14, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €220.00 | €257.30 | -14.50% | 24 | Oct 6, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €210.00 | €217.60 | -3.49% | 23 | Oct 6, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 225p → 300p | 207p | +45.21% | 32 | Sep 30, 2026 | |
| AIM: 4BB 4basebio PLC | Reiterated: Buy | 1,400p → 1,000p | 520p | +92.31% | 5 | Sep 28, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 900p | 508p | +77.17% | 33 | Sep 28, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €21.00 | €24.50 | -14.29% | 9 | Aug 12, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €32.00 | €32.92 | -2.79% | 2 | Aug 6, 2026 | |
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,350p → 1,250p | 1,067p | +17.15% | 2 | Aug 6, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 760.00 | CHF 593.80 | +27.99% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 215p → 315p | 235p | +33.81% | 15 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 110.00 | CHF 81.80 | +34.47% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 44.00 | CHF 44.10 | -0.23% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 108.00 → CHF 96.00 | CHF 70.20 | +36.75% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,900p | 1,219p | +55.87% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $70.11 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $281 | $99.17 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 310p | 248p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 26.00 | CHF 3.00 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 287.00 | kr 35.34 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 160p | 71p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.84 | $0.6317 | n/a | 8 | Apr 24, 2018 |
Evotec SE
Oct 14, 2026
Reiterated: Buy
Price Target: €10.00
Current: €2.62
Upside: +281.97%
Sartorius Aktiengesellschaft
Oct 6, 2026
Reiterated: Hold
Price Target: €220.00
Current: €257.30
Upside: -14.50%
Sartorius Stedim Biotech S.A.
Oct 6, 2026
Reiterated: Buy
Price Target: €210.00
Current: €217.60
Upside: -3.49%
Oxford Nanopore Technologies plc
Sep 30, 2026
Reiterated: Buy
Price Target: 225p → 300p
Current: 207p
Upside: +45.21%
4basebio PLC
Sep 28, 2026
Reiterated: Buy
Price Target: 1,400p → 1,000p
Current: 520p
Upside: +92.31%
Oxford Biomedica plc
Sep 28, 2026
Reiterated: Buy
Price Target: 900p
Current: 508p
Upside: +77.17%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Reiterated: Buy
Price Target: €21.00
Current: €24.50
Upside: -14.29%
Carl Zeiss Meditec AG
Aug 6, 2026
Reiterated: Hold
Price Target: €32.00
Current: €32.92
Upside: -2.79%
Smith & Nephew plc
Aug 6, 2026
Reiterated: Hold
Price Target: 1,350p → 1,250p
Current: 1,067p
Upside: +17.15%
Lonza Group AG
Aug 3, 2026
Reiterated: Buy
Price Target: CHF 760.00
Current: CHF 593.80
Upside: +27.99%
Aug 2, 2026
Reiterated: Buy
Price Target: 215p → 315p
Current: 235p
Upside: +33.81%
Jul 31, 2026
Reiterated: Buy
Price Target: CHF 110.00
Current: CHF 81.80
Upside: +34.47%
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 44.10
Upside: -0.23%
Mar 16, 2026
Reiterated: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 70.20
Upside: +36.75%
Mar 4, 2026
Reiterated: Buy
Price Target: 1,900p
Current: 1,219p
Upside: +55.87%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $70.11
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $281
Current: $99.17
Upside: n/a
Nov 19, 2024
Reiterated: Buy
Price Target: 310p
Current: 248p
Upside: n/a
Jul 12, 2021
Reiterated: Buy
Price Target: CHF 26.00
Current: CHF 3.00
Upside: n/a
Apr 13, 2021
Reiterated: Buy
Price Target: kr 287.00
Current: kr 35.34
Upside: n/a
Nov 2, 2018
Reiterated: Buy
Price Target: 160p
Current: 71p
Upside: n/a
Apr 24, 2018
Reiterated: Buy
Price Target: $6.84
Current: $0.6317
Upside: n/a